Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Apr 26;23(1):144.
doi: 10.1186/s13054-019-2337-5.

Angiotensin II in ECMO patients: a word of caution

Elio Antonucci  1 , Fabio Silvio Taccone  2
Affiliations
Comment

Angiotensin II in ECMO patients: a word of caution

Elio Antonucci et al. Crit Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

N/A

Consent for publication

N/A

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Comment on

  • Angiotensin in ECMO patients with refractory shock.
    Ostermann M, Boldt DW, Harper MD, Lim GW, Gunnerson K. Ostermann M, et al. Crit Care. 2018 Nov 1;22(1):288. doi: 10.1186/s13054-018-2225-4. Crit Care. 2018. PMID: 30382926 Free PMC article. No abstract available.

References

    1. Ostermann M, Boldt DW, Harper MD, Lim GW, Gunnerson K. Angiotensin in ECMO patients with refractory shock. Crit Care. 2018;22(1):288. - PMC - PubMed
    1. Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21(1):234. - PMC - PubMed
    1. Zambelli V, Bellani G, Borsa R, Pozzi F, Grassi A, Scanziani M, et al. Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome. Intensive Care Med Exp. 2015;3:44. - PMC - PubMed
    1. Antonucci E, Agosta S, Sakr Y. Angiotensin II in vasodilatory shock: lights and shadows. Crit Care. 2017;21:277. - PMC - PubMed
    1. Senchenkova EY, Russell J, Vital SA, Yildirim A, Orr AW, Granger DN. A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation. FASEB J. 2018;32:3448–3456. - PubMed